Acadia Healthcare Co Inc header image

Acadia Healthcare Co Inc

ACHC

Equity

ISIN US00404A1097 / Valor 14151414

NASDAQ (2024-09-18)
USD 77.94+0.22%

Acadia Healthcare Co Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Acadia Healthcare Co Inc is a leading provider of behavioral healthcare services in the United States and Puerto Rico, operating 253 treatment facilities across 38 states. The company offers various levels of care for behavioral health and substance use disorders, including detoxification, residential treatment for addiction, acute psychiatric inpatient hospitalization, medication-assisted treatment services, and outpatient programming options. Acadia Healthcare aims to meet patients at different stages of their treatment process, providing a safe environment for individuals to receive the care they need. The company continues to expand its reach through the construction of new facilities, the acquisition of existing facilities, and partnerships with reputable organizations. With a focus on innovative, patient-centered approaches to treatment, Acadia Healthcare specializes in helping individuals of all ages who are struggling with mental health disorders and addiction.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Revenue Growth

Acadia Healthcare Co Inc reported revenue of $796.0 million for the second quarter of 2024, marking an 8.8% increase compared to the same period in 2023. This growth was driven by a combination of higher revenue per patient day and an increase in patient days.

Net Income

For the second quarter of 2024, Acadia Healthcare Co Inc achieved a net income of $78.5 million, or $0.85 per diluted share. This represents a significant improvement over the net income reported in the second quarter of 2023.

Adjusted EBITDA

Acadia Healthcare Co Inc's adjusted EBITDA for the second quarter of 2024 was $187.6 million, reflecting a 7.6% increase from the second quarter of 2023. This growth underscores the company's strong operational performance and effective cost management.

Strategic Investments

During the second quarter of 2024, Acadia Healthcare Co Inc added 37 beds to its existing facilities and opened a new 100-bed acute care hospital in Mesa, Arizona. The company remains on track to add approximately 1,200 beds in 2024, including new Comprehensive Treatment Centers.

Financial Guidance

Acadia Healthcare Co Inc revised its financial guidance for 2024, projecting revenue between $3.180 billion and $3.225 billion. The company also expects adjusted EBITDA to range from $735 million to $765 million, reflecting its strategic growth initiatives and market demand.

Summarized from source with an LLMView Source

Key figures

11.4%1Y
27.3%3Y
141%5Y

Performance

32.3%1Y
33.3%3Y
46.8%5Y

Volatility

Market cap

7222 M

Market cap (USD)

Daily traded volume (Shares)

259,667

Daily traded volume (Shares)

1 day high/low

78.565 / 77.04

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Sanofi SA
Sanofi SA Sanofi SA Valor: 699381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.06%EUR 102.96
Sartorius Stedim Biotech
Sartorius Stedim Biotech Sartorius Stedim Biotech Valor: 32518471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.02%EUR 179.65
bioMerieux SA
bioMerieux SA bioMerieux SA Valor: 38147803
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.19%EUR 107.30
Ipsen
Ipsen Ipsen Valor: 2348805
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.62%EUR 109.00
Interparfums
Interparfums Interparfums Valor: 86977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.71%EUR 41.30
Ste Virbac SA
Ste Virbac SA Ste Virbac SA Valor: 524407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.42%EUR 392.00
Ramsay Generale de Sante SA
Ramsay Generale de Sante SA Ramsay Generale de Sante SA Valor: 1247709
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.35%EUR 14.60
Robertet SA
Robertet SA Robertet SA Valor: 510354
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.96%EUR 947.00
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%EUR 32.75
Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.30%EUR 27.34